# A Study of Lu AG06466 for the Treatment of Spasticity in Participants With Multiple Sclerosis

> **NCT04990219** · PHASE1 · TERMINATED · sponsor: **H. Lundbeck A/S** · enrollment: 37 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Lu AG06466
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04990219
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-09-27
- **Primary completion:** 2023-01-19
- **Final completion:** 2023-01-31
- **Target enrollment:** 37 (ACTUAL)
- **Why stopped:** The study was terminated for strategic reasons
- **Last updated:** 2023-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04990219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04990219, "A Study of Lu AG06466 for the Treatment of Spasticity in Participants With Multiple Sclerosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04990219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*